Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Aug 31, 16:00
Kezar Life Sciences Cash and Short Term Investments (Quarterly) : 66.23M for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 66.23M |
| December 31, 2025 | 71.88M |
| September 30, 2025 | 90.22M |
| June 30, 2025 | 100.85M |
| March 31, 2025 | 114.36M |
| December 31, 2024 | 132.24M |
| September 30, 2024 | 148.39M |
| June 30, 2024 | 164.18M |
| March 31, 2024 | 179.80M |
| December 31, 2023 | 201.37M |
| September 30, 2023 | 218.20M |
| June 30, 2023 | 236.59M |
| March 31, 2023 | 257.67M |
| December 31, 2022 | 276.56M |
| September 30, 2022 | 290.38M |
| June 30, 2022 | 306.84M |
| March 31, 2022 | 242.61M |
| Date | Value |
|---|---|
| December 31, 2021 | 208.36M |
| September 30, 2021 | 120.76M |
| June 30, 2021 | 128.98M |
| March 31, 2021 | 142.31M |
| December 31, 2020 | 140.45M |
| September 30, 2020 | 149.95M |
| June 30, 2020 | 157.47M |
| March 31, 2020 | 123.35M |
| December 31, 2019 | 78.21M |
| September 30, 2019 | 85.24M |
| June 30, 2019 | 93.42M |
| March 31, 2019 | 101.13M |
| December 31, 2018 | 107.43M |
| September 30, 2018 | 112.76M |
| June 30, 2018 | 118.38M |
| March 31, 2018 | 47.08M |
| December 31, 2017 | 51.03M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| NovelStem International Corp. | 0.0562M |
| Brainstorm Cell Therapeutics, Inc. | 0.022M |
| Summit Therapeutics, Inc. | 691.00M |
| Protara Therapeutics, Inc. | 142.49M |
| Clene, Inc. | 9.671M |